Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Gene Logic and Japan Tobacco enter genomic alliance

Sep. 15, 1997

NC-1800 now in phase II development

Sep. 15, 1997

PharmaPrint begins phase II trial of herbal treatment for BPH

Sep. 11, 1997

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Sep. 9, 1997

Agents useful for BPH from Pfizer

Sep. 9, 1997

Attenuation of cyclophosphamide-induced bladder damage in animals by GR-203040

Sep. 9, 1997

Uroselective alpha1-adrenoceptor antagonists for BPH

Sep. 8, 1997

Antioxidant from Otsuka effective in animal model of nephritis

Sep. 5, 1997

New aldosterone antagonists from Yamanouchi

Aug. 26, 1997

ETA/ETB antagonist protects against renal insufficiency in canine model

Aug. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...